HGH 20 IU

Quickstart Highlights

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH, studied extensively for its effects on body composition, metabolism, and tissue repair[1][7]. Clinical protocols typically employ subcutaneous administration once daily to mimic physiological GH secretion patterns[2][3]. This educational protocol presents a gradual titration approach using practical dilution for precise insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.11 mg/mL concentration (~1111 mcg/mL).
Typical daily range: 150–500 mcg (conservative replacement protocols)[1] to 1000–2000 mcg (advanced metabolic studies)[4]. Open source
Easy measuring: At 1.11 mg/mL, 1 unit = 0.01 mL ≈ 11.1 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Extended 12-Week Protocol (Optional)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Week 9	1000 mcg	90 units (0.90 mL)
Week 10	1100 mcg	99 units (0.99 mL)
Week 11	1200 mcg	108 units (1.08 mL)
Week 12	1300 mcg	117 units (1.17 mL)

Frequency: Inject once daily subcutaneously, preferably at bedtime to mimic physiological GH secretion[2]. Rotate injection sites to prevent lipoatrophy[3]. This 8-week protocol represents a conservative approach with gradual dose escalation by approximately 100 mcg per week.
Note: The 12-week extension reaches higher daily doses (1000–1300 mcg) that have been explored in performance and metabolic research settings[4]. These doses yield more significant physiological effects but also increase the potential for side effects. Further extension to 16 weeks (reaching 1700 mcg daily) may be considered in advanced protocols, though such aggressive regimens should be undertaken with appropriate monitoring.

Reconstitution Steps

Reference-derived details for HGH 20 IU.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously to preserve protein structure)[5]. Open source
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (HGH 191AA, 10 IU / 3.33 mg each):
Peptide Vials (HGH 191AA, 10 IU / 3.33 mg each):: 8 weeks ≈ 10 vials
Peptide Vials (HGH 191AA, 10 IU / 3.33 mg each):: 12 weeks ≈ 19 vials
Peptide Vials (HGH 191AA, 10 IU / 3.33 mg each):: 16 weeks ≈ 32 vials
Insulin Syringes (U-100):
Insulin Syringes (U-100):: Per week: 7 syringes (1/day)
Insulin Syringes (U-100):: 8 weeks: 56 syringes
Insulin Syringes (U-100):: 12 weeks: 84 syringes
Insulin Syringes (U-100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (10 vials): 30 mL → 3 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (19 vials): 57 mL → 6 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 16 weeks (32 vials): 96 mL → 10 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support increases in lean body mass, reductions in adipose tissue, and enhanced metabolic function[7][8]. Open source
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired for advanced protocols).
Dose Range: Conservative: 150–500 mcg daily[1]; Advanced: 1000–2000 mcg daily[4]. Open source
Reconstitution: 3.0 mL per 3.33 mg vial (~1.11 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

Start: 200 mcg daily; increase by ~100 mcg each week as tolerated.
Conservative Target: 400–900 mcg daily by Weeks 4–8[1][8]. Open source
Advanced Target: 1000–1300 mcg daily by Weeks 9–12 (performance/metabolic research protocols)[4]. Open source
Frequency: Once per day (subcutaneous), preferably at bedtime[2]. Open source
Cycle Length: 8–12 weeks standard; optional extension to 16 weeks with appropriate monitoring.
Timing: Evening or bedtime administration preferred; rotate injection sites systematically[3]. Open source

Storage Instructions

Proper storage preserves peptide quality and bioactivity.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); stable for several weeks when stored properly[5]. Open source
Allow vials to reach room temperature before opening to reduce condensation uptake.
Critical: Avoid freeze–thaw cycles of reconstituted peptide, as freezing can denature the protein[5]. Open source

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and prevent lipoatrophy[3]. Open source
Inject slowly; wait a few seconds before withdrawing the needle to minimize leakage.
Document daily dose, injection site, and any observed effects to maintain consistency and track tolerance.
HGH must be administered by injection; oral administration would be ineffective due to peptide degradation in the digestive system[6]. Open source

How This Works

HGH 191AA is recombinant human growth hormone (somatropin) that is structurally identical to endogenous GH secreted by the pituitary gland[1][5]. Clinical studies demonstrate that GH administration promotes increases in lean body mass, reductions in adipose tissue, and improvements in body composition through multiple mechanisms including enhanced lipolysis, increased protein synthesis, and stimulation of IGF-1 production[7][8]. Pivotal research by Rudman and colleagues showed that six months of HGH administration in older men significantly increased lean body mass and decreased adipose mass compared to placebo[7]. Long-term follow-up studies in adults with GH deficiency have demonstrated sustained improvements in muscle strength and body composition with maintenance dosing[8].

Subcutaneous administration once daily, particularly at bedtime, is designed to mimic physiological patterns of endogenous GH secretion[2][3]. Dosing protocols vary based on therapeutic goals: conservative replacement protocols typically employ 150–500 mcg daily[1], while advanced metabolic and performance research protocols may utilize 1000–2000 mcg daily[4]. Higher doses produce more pronounced physiological effects but also carry increased risk of side effects including fluid retention, joint discomfort, and potential metabolic disturbances[2].

Potential Benefits & Side Effects

Observations from clinical research literature.

Increases in lean body mass and reductions in adipose tissue in clinical studies[7][8]. Open source
Enhanced fat oxidation and lipolysis in dose-dependent manner[4]. Open source
Sustained improvements in muscle strength and body composition with long-term use in GH-deficient adults[8]. Open source
Improved metabolic parameters in appropriate clinical contexts[1][2]. Open source
Injection site reactions (redness, irritation); can be minimized by proper rotation technique[3]. Open source
Fluid retention and peripheral edema, particularly at higher doses[2]. Open source
Joint discomfort or arthralgias reported in some clinical protocols.
Potential glucose metabolism effects; monitoring may be warranted in extended protocols[2]. Open source
Risk of lipoatrophy at injection sites if rotation is inadequate[3]. Open source
Note: While research in healthy athletes showed GH increased lean body mass, it did not significantly improve muscle strength or exercise performance in systematic reviews[10]. Side effects and benefits are dose-dependent, with higher doses yielding more pronounced effects but also increased risk profiles.

Lifestyle Factors

Complementary strategies for optimizing outcomes.

Maintain adequate protein intake (1.6–2.2 g/kg body weight) to support anabolic processes stimulated by GH.
Combine resistance training and progressive overload to maximize lean mass gains and strength improvements.
Include cardiovascular activity to enhance metabolic adaptations and fat oxidation.
Prioritize sleep quality and duration (7–9 hours) to support endogenous recovery processes.
Manage stress and cortisol levels, as chronic stress can interfere with GH signaling and metabolic outcomes.
Ensure adequate hydration, particularly at higher doses where fluid retention may occur.

Injection Technique

Subcutaneous injection guidance from clinical best-practice resources[11][12].

Clean the vial stopper and injection site with alcohol; allow to air dry completely.
Pinch a skinfold at the injection site; insert the needle at 45–90° into subcutaneous tissue[11]. Open source
Do not aspirate for subcutaneous injections; inject slowly and steadily[11]. Open source
Rotate sites systematically (abdomen, thighs, upper arms) to prevent lipohypertrophy and lipoatrophy[3][13]. Open source
Common subcutaneous sites: abdomen (at least 2 inches from navel), outer thighs, upper arms (posterior surface)[12]. Open source
Wait a few seconds after injection before withdrawing needle to minimize solution leakage.

Recommended Source

We recommend Prime Lab Peptides for high-purity HGH 191AA (10 IU / 3.33 mg).

High-purity recombinant somatropin with third-party testing and batch COAs.
Consistent, ISO-aligned handling and quality documentation.
Reliable fulfillment with proper cold-chain logistics to maintain product integrity.
Transparent sourcing and comprehensive product information.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References